New Drug Approvals

Home | Pages | Archives

• GFT 505, Elafibranor, элафибранор , إيلافيبرانور , 依非兰诺  May 28, 2018 - (0)
  
  

  (E)-Elafibranor Molecular FormulaC22H24O4S Average mass384.489 Da Elafibranor CAS 824932-88-9  E Z MIXTURE USAN CAS 923978-27-2 E ISOMER INN 2-(2,6-Dimethyl-4-{3-[4-(methylsulfanyl)phenyl]-3-oxo-1-propen-1-yl}phenoxy)-2-methylpropanoic acid Elafibranor(GFT505) GFT505;GFT-505;GFT 505 UNII:2J3H5C81A5 (E)-Elafibranor 2-(2,6-Dimethyl-4-{(1E)-3-[4-(methylsulfanyl)phenyl]-3-oxo-1-propen-1-yl}phenoxy)-2-methylpropanoic acid 2-(2,6-Dimethyl-4-{(1E)-3-[4-(methylsulfanyl)phenyl]-3-oxo-1-propen-1-yl}phenoxy)-2-methylpropansäure 2J3H5C81A5 CAS 923978-27-2 E ISOMER INN Acide 2-(2,6-diméthyl-4-{(1E)-3-[4-(méthylsulfanyl)phényl]-3-oxo-1-propén-1-yl}phénoxy)-2-méthylpropanoïque[French] [ACD/IUPAC Name] GFT505 Propanoic acid, 2-[2,6-dimethyl-4-[(1E)-3-[4-(methylthio)phenyl]-3-oxo-1-propen-1-yl]phenoxy]-2-methyl- UNII-2J3H5C81A5 (E)-2-(2,6-Dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxoprop-1-en-1-yl)phenoxy)-2-methylpropanoic acid элафибранор[Russian][INN] إيلافيبرانور[Arabic][INN] 依非兰诺[Chinese][INN] UNII-2J3H5C81A5 Treatment of Non-Alcoholic Steato-Hepatitis, Reducing Cardiometabolic Risk Factors in Patients with Diabetes […]

• Specific Stereoisomeric Conformations Determine the Drug Potency of Cladosporin Scaffold against Malarial Parasite May 27, 2018 - (0)
• PF 06650833 May 26, 2018 - (0)
• LRH-1 agonism favours an immune-islet dialogue which protects against diabetes mellitus May 22, 2018 - (0)
• FDA approves new drug Doptelet (avatrombopag) for patients with chronic liver disease who have low blood platelets and are undergoing a medical procedure May 22, 2018 - (1)

« Older Newer »

Mobile Site | Full Site

Get a free blog at WordPress.com Theme: WordPress Mobile Edition by Alex King.